Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Drug Metabolism
|
March 15, 2011
NSAID acyl glucuronides and enteropathy
Urs A Boelsterli, Veronica Ramirez-Alcantara
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
May 27, 2010
Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy
Veronica Ramirez-Alcantara, Amanda LoGuidice, Urs A Boelsterli
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 30, 2010
Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice
Amanda LoGuidice, Veronica Ramirez-Alcantara, Anthony Proli, et al.
Kidney International Reports
|
May 20, 2021
Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling
Guillermo A Herrera, Luis Del Pozo-Yauner, Jiamin Teng, et al.
Gynecologic Oncology
|
July 24, 2025
Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage
Kevin J Lee, Sagar Chokshi, Tanvi Joshi, et al.
Cancer Letters
|
May 4, 2026
Angiotensin II Type 1 Receptor Blockade Inhibits Gastric Cancer Metastasis Through Tight Junction Restoration
Sooraj Kakkat, Prabhat Suman, Sandeep Goswami, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2019
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
Aleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Oncotarget
|
October 21, 2017
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling
Bing Zhu, Ashley Lindsey, Nan Li, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2026
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 29, 2021
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
Kevin J Lee, Wen-Chi L Chang, Xi Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Drug Metabolism
|
March 15, 2011
NSAID acyl glucuronides and enteropathy
Urs A Boelsterli, Veronica Ramirez-Alcantara
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
May 27, 2010
Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy
Veronica Ramirez-Alcantara, Amanda LoGuidice, Urs A Boelsterli
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 30, 2010
Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice
Amanda LoGuidice, Veronica Ramirez-Alcantara, Anthony Proli, et al.
Kidney International Reports
|
May 20, 2021
Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling
Guillermo A Herrera, Luis Del Pozo-Yauner, Jiamin Teng, et al.
Gynecologic Oncology
|
July 24, 2025
Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage
Kevin J Lee, Sagar Chokshi, Tanvi Joshi, et al.
Cancer Letters
|
May 4, 2026
Angiotensin II Type 1 Receptor Blockade Inhibits Gastric Cancer Metastasis Through Tight Junction Restoration
Sooraj Kakkat, Prabhat Suman, Sandeep Goswami, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 6, 2019
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
Aleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Oncotarget
|
October 21, 2017
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling
Bing Zhu, Ashley Lindsey, Nan Li, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2026
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 29, 2021
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
Kevin J Lee, Wen-Chi L Chang, Xi Chen, et al.
Page
of 2